WAY-163909, a 5-HT2C agonist, enhances the preclinical potency of current antipsychotics.

Saved in:

Bibliographic Details
Title:	WAY-163909, a 5-HT2C agonist, enhances the preclinical potency of current antipsychotics.
Authors:	Grauer, Steven¹ grauers@wyeth.com, Graf, Radka¹, Navarra, Rachel¹, Sung, Amy¹, Logue, Sheree¹, Stack, Gary², Huselton, Christine³, Liu, Zhi³, Comery, Thomas¹, Marquis, Karen¹, Rosenzweig-Lipson, Sharon¹
Source:	Psychopharmacology. May2009, Vol. 204 Issue 1, p37-48.
Database:	SPORTDiscus with Full Text

Description
ISSN:	00333158
DOI:	10.1007/s00213-008-1433-z